Publication date: 10 September 2026 Source: Molecular Therapy Advances, Volume 34, Issue 3 Author(s): Slawomir Wantuch, Steven Tuske, Sara Benedetti, Nickita Mehta, Jon J. Brudvig, Hung Do, Russell Gotschall, Jessie Feng, Anna B. Gaspar, Chiara Recchi, Paul Heal, Tyler B. Johnson, Fulvio Mavilio, Pervinder Sagoo, Jill M. Weimer, H. Bobby Gaspar
GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease. // Molecular Therapy Advances. – URL: https://www.sciencedirect.com/science/article/pii/S3117387X2600159X?dgcid=rss_sd_all
GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease. Molecular Therapy Advances. https://www.sciencedirect.com/science/article/pii/S3117387X2600159X?dgcid=rss_sd_all
“GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease.” Molecular Therapy Advances.
@article{article117416,
title = {GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease},
journal = {Molecular Therapy Advances},
url = {https://www.sciencedirect.com/science/article/pii/S3117387X2600159X?dgcid=rss_sd_all}
}